Showing results (231-240 of 343) with videos related to
Sort By:
Pageof 35
ESMO Open|February 26, 2022
Drug-induced interstitial lung disease during cancer therapies: expert opinion on diagnosis and treatmentP Conte, P A Ascierto, G Patelli, et al.The American Journal of Cardiology|March 1, 1985
Electrophysiologic evaluation and follow-up characteristics of patients with recurrent unexplained syncope and presyncopeJ U Doherty, D Pembrook-Rogers, E W Grogan, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 1, 2010
Early magnesium modifications as a surrogate marker of efficacy of cetuximab-based anticancer treatment in KRAS wild-type advanced colorectal cancer patientsB Vincenzi, S Galluzzo, D Santini, et al.Tumori|March 1, 1997
Postoperative adjuvant chemoradiotherapy for rectal cancer: analysis of acute and chronic toxicityM Bertuccelli, F Cartei, A Falcone, et al.British Journal of Cancer|March 26, 2008
A pharmacokinetic and pharmacodynamic study on metronomic irinotecan in metastatic colorectal cancer patientsG Allegrini, A Falcone, A Fioravanti, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 11, 2008
Bortezomib, doxorubicin and dexamethasone in advanced multiple myelomaA Palumbo, F Gay, S Bringhen, et al.British Journal of Cancer|March 17, 2011
Pharmacodynamic and pharmacogenetic angiogenesis-related markers of first-line FOLFOXIRI plus bevacizumab schedule in metastatic colorectal cancerF Loupakis, C Cremolini, A Fioravanti, et al.Blood|June 20, 1998
Splenectomy and risk of blast transformation in myelofibrosis with myeloid metaplasia. Italian Cooperative Study Group on Myeloid with Myeloid MetaplasiaG Barosi, A Ambrosetti, A Centra, et al.Journal of Neurology|December 20, 2014
Sniff nasal inspiratory pressure as a prognostic factor of tracheostomy or death in amyotrophic lateral sclerosisRosa Capozzo, Vitaliano N Quaranta, Fabio Pellegrini, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 20, 2011
An EZH2 polymorphism is associated with clinical outcome in metastatic colorectal cancer patientsF Crea, L Fornaro, E Paolicchi, et al.Pageof 35